HEK293 TLR9 NF-κB Luciferase Reporter Cell Line

HEK293 TLR9 NF-κB Luciferase Reporter Cell Line

Item	Cat#	Price
Stable Cell Line	SNB-SP-0038	$1,980
Compound Test Services	CT-001	$1,850 per 384w plate *(Up To 16 cpds Dose)*

Ask For A Custom Quote

Product Description

The NF-κB (Nuclear Factor Kappa B) signaling pathway is a central pathway regulating inflammation, immunity, cell survival, and proliferation. In its inactive state, NF-κB (typically a p50/p65 dimer) is bound to the inhibitory protein IκB and sequestered in the cytoplasm. Upon cellular stimulation by external signals (e.g., TNF-α, bacterial LPS), the IκB kinase (IKK) complex is activated, leading to phosphorylation and subsequent ubiquitin-mediated degradation of IκB. The released NF-κB then translocates into the nucleus, where it binds to specific DNA sequences to initiate the transcription of various target genes (such as cytokines, chemokines, and anti-apoptotic proteins), thereby participating in immune responses, inflammatory reactions, and tumorigenesis.

Screeningbio’s HEK293/TLR9 NF-κB Luciferase Reporter cell line stable expressing TLR9 receptor (Toll-like receptor) in the HEK293 NFκB-luciferase parental cell.

Product Specifications

Target Type	Signal Pathway
Species	Human
HGNC Symbol
Accession Number
Parental Line	HEK293
Lot#	See Vial
Storage	Liquid Nitrogen

Data

HEK293/TLR9 NF-κB Luciferase Agonist Assay. HEK293/TLR9 NF-κB Luciferase reporter cells were treated with Flagellin. The assay was run based on Promega ONE-GLOTM Luciferase Assay System. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software. — **HEK293/TLR9 NF-κB Luciferase Agonist Assay.** HEK293/TLR9 NF-κB Luciferase reporter cells were treated with Flagellin. The assay was run based on Promega ONE-GLO^TM Luciferase Assay System. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.

Target Background

The NF-κB (Nuclear Factor Kappa B) signaling pathway is a central pathway regulating inflammation, immunity, cell survival, and proliferation. In its inactive state, NF-κB (typically a p50/p65 dimer) is bound to the inhibitory protein IκB and sequestered in the cytoplasm. Upon cellular stimulation by external signals (e.g., TNF-α, bacterial LPS), the IκB kinase (IKK) complex is activated, leading to phosphorylation and subsequent ubiquitin-mediated degradation of IκB. The released NF-κB then translocates into the nucleus, where it binds to specific DNA sequences to initiate the transcription of various target genes (such as cytokines, chemokines, and anti-apoptotic proteins), thereby participating in immune responses, inflammatory reactions, and tumorigenesis.